Sign in

Filings

Finds words inside filing documents. Searching Regen BioPharma Inc's filings · 20 documents indexed.

9 documents · 32 matches

  1. RGBP Regen BioPharma Inc 10-K 2025-12-30

    Item 15. Exhibit Index

    Going Concern – As discussed in Note 2 to the financial statements, the Company has a going concern due to negative
    7 matches in this document

  2. RGBP Regen BioPharma Inc 10-K 2025-05-13

    Item 8. Financial Statements and Supplementary Data

    Going Concern – As discussed in Note 2 to the consolidated financial statements, the Company has a going concern due to negative
    6 matches in this document

  3. RGBP Regen BioPharma Inc 10-Q 2026-08-17

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    going concern. The Company has incurred significant operating losses and negative cash flows from operations since inception. As of June
    4 matches in this document

  4. RGBP Regen BioPharma Inc 10-Q 2026-05-14

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    going concern. The Company has incurred significant operating losses and negative cash flows from operations since inception. As of March
    4 matches in this document

  5. RGBP Regen BioPharma Inc 10-Q 2026-02-13

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    going concern. The Company has incurred significant operating losses and negative cash flows from operations since inception. As of December
    4 matches in this document

  6. RGBP Regen BioPharma Inc 10-Q 2025-08-11

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    going concern. The Company has incurred significant operating losses and negative cash flows from operations since inception. As of June
    4 matches in this document

  7. RGBP Regen BioPharma Inc 10-Q 2025-05-28

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    going concern. The Company has incurred significant operating losses and negative cash flows from operations since inception. As of March
    1 match in this document

  8. RGBP Regen BioPharma Inc 10-Q 2025-05-16

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

    going concern. The Company has incurred significant operating losses and negative cash flows from operations since inception. As of December
    1 match in this document

  9. RGBP Regen BioPharma Inc 8-K 2026-07-15

    Item 4.01. Changes in Registrant’s Certifying Accountant

    explanatory paragraph indicating that there was substantial doubt as to the Company’s ability to continue as a going concern.
    1 match in this document

Page 1 of 1 · 9 documents